Atea Pharmaceuticals's total assets for Q4 2024 were $464.67M, a decrease of -5.35% from the previous quarter. AVIR total liabilities were $25.80M for the fiscal quarter, a -20.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.